Nova Mentis Life Science Corp (NOVA.CX)
0.015
0.00 (0.00%)
CAD |
CNSX |
Jun 17, 16:00
Nova Mentis Life Science Net Income (Quarterly): -0.1444M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.1444M |
| September 30, 2023 | -0.1841M |
| March 31, 2023 | -0.528M |
| December 31, 2022 | -1.069M |
| September 30, 2022 | -0.4029M |
| June 30, 2022 | -0.3668M |
| March 31, 2022 | -0.6269M |
| December 31, 2021 | -0.2436M |
| September 30, 2021 | -1.403M |
| June 30, 2021 | -0.421M |
| March 31, 2021 | -0.6169M |
| December 31, 2020 | -18.07M |
| September 30, 2020 | -0.5545M |
| June 30, 2020 | -6.425M |
| March 31, 2020 | -0.1838M |
| December 31, 2019 | -0.2505M |
| September 30, 2019 | -0.3439M |
| June 30, 2019 | -0.4705M |
| March 31, 2019 | -0.3331M |
| December 31, 2018 | -0.5497M |
| September 30, 2018 | -0.7554M |
| June 30, 2018 | -0.1947M |
| March 31, 2018 | -2.073M |
| December 31, 2017 | -0.7966M |
| September 30, 2017 | -0.4682M |
| Date | Value |
|---|---|
| June 30, 2017 | -0.3348M |
| March 31, 2017 | -0.2662M |
| December 31, 2016 | -1.598M |
| September 30, 2016 | -0.1941M |
| June 30, 2016 | -0.1982M |
| March 31, 2016 | -0.0852M |
| December 31, 2015 | -0.2393M |
| September 30, 2015 | -0.1709M |
| June 30, 2015 | -0.1113M |
| March 31, 2015 | -0.1677M |
| December 31, 2014 | -1.736M |
| September 30, 2014 | -0.119M |
| June 30, 2014 | -0.1331M |
| March 31, 2014 | -0.0725M |
| December 31, 2013 | -0.0913M |
| September 30, 2013 | -0.0904M |
| June 30, 2013 | -0.0245M |
| March 31, 2013 | -0.0571M |
| December 31, 2012 | -6.098M |
| September 30, 2012 | -0.2102M |
| June 30, 2012 | -0.1182M |
| March 31, 2012 | -0.1714M |
| December 31, 2011 | -2.424M |
| September 30, 2011 | -0.2148M |
| June 30, 2011 | -0.4514M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-18.07M
Minimum
Dec 2020
-0.1444M
Maximum
Mar 2024
-1.795M
Average
-0.4457M
Median
Net Income (Quarterly) Benchmarks
| Biocure Technology Inc | -0.0238M |
| Core One Labs Inc | -0.8407M |
| Nanosphere Health Sciences Inc | -0.0557M |
| Lobe Sciences Ltd | -0.5955M |
| Algernon Pharmaceuticals Inc | -1.88M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.1456M |
| EPS Diluted (Quarterly) | -0.001 |
| Enterprise Value | 2.263M |
| Earnings Yield | -105.7% |
| Normalized Earnings Yield | -82.56 |